Rocket


News + Filings
Transactions
Holdings





All
13F
13D/G
Other



Simon Barry J. Create: Alert

All | News | Filings
Date FiledTypeDescription
06/09/2023 4 Simon Barry J. (Director) has filed a Form 4 on Viracta Therapeutics, Inc.
Txns: Granted 40,000 options to buy @ $1.5, valued at $60k
06/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/25/2022 4 Simon Barry J. (Director) has filed a Form 4 on ImmunityBio, Inc.
Txns: Granted 10,714 options to buy @ $5.83, valued at $62.5k
01/28/2022 5 Simon Barry J. (Director) has filed a Form 5 on ImmunityBio, Inc.
05/25/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/07/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/30/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/04/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
02/08/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/04/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/29/2021 4 Simon Barry J. (See remarks) has filed a Form 4 on NantKwest, Inc.
Txns: Sold 36,626 shares @ $20.6123, valued at $754.9k
Sold 11,304 shares @ $20.5344, valued at $232.1k
Exercised 36,626 options to buy @ $1.9984, valued at $73.2k
Exercised 11,304 options to buy @ $1.9984, valued at $22.6k
01/06/2021 4 Simon Barry J. (Director) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Granted 10,000 options to buy @ $12.36, valued at $123.6k
12/28/2020 4 Simon Barry J. (See remarks) has filed a Form 4 on NantKwest, Inc.
Txns: Sold 130,000 shares @ $18.0508, valued at $2.3M
Exercised 130,000 options to buy @ $1.9984, valued at $259.8k
07/22/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/10/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/02/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/23/2020 4 Simon Barry J. (See remarks) has filed a Form 4 on NantKwest, Inc.
Txns: Sold 13,737 shares @ $9.0003, valued at $123.6k
Sold 66,263 shares @ $9.4292, valued at $624.8k
Sold 80,000 shares @ $10.5458, valued at $843.7k
Sold 10,432 shares @ $13.0089, valued at $135.7k
Sold 29,609 shares @ $13.0073, valued at $385.1k
Exercised 9,337 options to buy @ $1.7554, valued at $16.4k
Exercised 136,729 options to buy @ $1.7554, valued at $240k
Exercised 29,609 options to buy @ $1.7554, valued at $52k
05/29/2020 4 Simon Barry J. (See remarks) has filed a Form 4 on NantKwest, Inc.
Txns: Sold 75,000 shares @ $7.5645, valued at $567.3k
05/22/2020 4 Simon Barry J. (See remarks) has filed a Form 4 on NantKwest, Inc.
Txns: Sold 36,932 shares @ $5.5155, valued at $203.7k
05/13/2020 4 Simon Barry J. (See remarks) has filed a Form 4 on NantKwest, Inc.
Txns: Sold 28,068 shares @ $5.5048, valued at $154.5k
01/06/2020 4 Simon Barry J. (Director) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Granted 9,600 options to buy @ $16.31, valued at $156.6k
01/03/2019 4 Simon Barry J. (Director) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Granted 9,600 options to buy @ $5.16, valued at $49.5k
08/29/2018 4 Simon Barry J. (See remarks) has filed a Form 4 on NantKwest, Inc.
Txns: Granted 200,000 options to buy @ $3.07, valued at $614k
06/14/2018 4 Simon Barry J. (Director) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Exercised 8,000 options to buy @ $14.24, valued at $113.9k
02/13/2018 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
12/27/2017 3 Simon Barry J. (Director) has filed a Form 3 on Cue Biopharma, Inc.
09/09/2016 4 Simon Barry J. (President and COO) has filed a Form 4 on NantKwest, Inc.
Txns: Sold 2,000 shares @ $8.8356, valued at $17.7k
Sold 30,000 shares @ $7.4, valued at $222k
07/28/2016 4 Simon Barry J. (President and COO) has filed a Form 4 on NantKwest, Inc.
Txns: Paid exercise price by delivering 79,322 shares @ $6.89, valued at $546.5k
Exercised 185,150 restricted stock units @ $0

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy